Lallemand Health Solutions, headquartered in Mirabel, Quebec, Canada, is a globally recognized manufacturer and developer of probiotic solutions for human health. As a division of the larger Lallemand Inc., a privately owned Canadian company with over 100 years of expertise in microbiology, Lallemand Health Solutions specializes in the development, production, and commercialization of bacteria and yeast-based probiotic products targeting multiple areas of human health and wellness.
Core Business and Product Portfolio
Lallemand Health Solutions offers a robust portfolio of science-backed probiotic strains and formulations, serving over 60 countries through B2B partnerships with pharmaceutical, nutraceutical, and functional food companies.
1. Probiotic Supplements
- Comprises over 600 probiotic formulas, available in:
- Capsules
- Sachets
- Chewable tablets
- Lozenges
- Powders
- Health categories covered:
- Gut Health: IBS, diarrhea, constipation, bloating
- Immune Health: General immunity and respiratory support
- Mental Health: Probiotics for mood and stress (psychobiotics)
- Women’s Health: Vaginal health, urinary tract support
- Children and Infant Health: Pediatric-specific strains and safety-tested products
- Key branded formulations include:
- IBacilluS+™, Lafti® B94, Rosell®-52, Lacidofil®, among others
2. Enriched Yeasts
- Yeast-based products fortified with:
- Vitamins (B-complex, D)
- Minerals (Selenium, Chromium, Zinc)
- Used in:
- Nutritional supplements
- Fortified food and beverage products
- Infant nutrition and sports nutrition
Manufacturing and Quality Control
Lallemand Health Solutions operates 3 cGMP-compliant manufacturing plants and 7 proprietary fermentation facilities, enabling:
- Annual production of over 600 metric tons of active probiotic biomass
- Proprietary cryoprotective and lyophilization techniques to ensure cell viability
- On-site analytical laboratories for:
- Viable cell count verification
- Genetic strain identification
- Stability and shelf-life testing
Certifications held:
- ISO 9001:2015
- cGMP (current Good Manufacturing Practices)
- Health Canada Site Licensing
- NSF International GMP Registration
- Non-GMO, Kosher, and Halal Certifications for select products
Global Market Reach and Export Activity
Lallemand Health Solutions exports to more than 60 countries worldwide through a network of B2B partners and distributors.
Trade and export data highlights:
- Estimated annual revenue for Lallemand Group exceeds CAD 1 billion, with the health solutions division contributing significantly through probiotic-based ingredients and finished product formulations
- Export volume of probiotic bulk ingredients and finished products exceeds 1000 metric tons annually
- Key markets: North America, Europe, Southeast Asia, Latin America, and MENA
Products are custom formulated to meet regulatory requirements across global jurisdictions, including:
- EFSA (Europe)
- FDA GRAS status (USA)
- CFDA (China)
- ANVISA (Brazil)
R&D and Scientific Validation
A core strength of Lallemand Health Solutions lies in its science-driven product development:
- Collaborations with 40+ research institutions worldwide
- Over 160 published studies, including 70+ clinical trials
- Strain-specific research on safety, efficacy, and mechanism of action
- Dedicated Clinical Research and Medical Affairs teams ensure ongoing validation and evidence-based claims
Their innovation hub works closely with clients to develop custom blends, novel delivery forms, and regulatory dossiers for product registration.
Target Markets and Customers
Lallemand Health Solutions serves:
- Pharmaceutical companies seeking clinically supported probiotics
- Nutraceutical and functional food brands
- Private label product developers
- Infant and pediatric health brands
- Online wellness platforms and healthcare professionals
The company provides turnkey contract manufacturing, regulatory support, and customized formulation services, making it a strategic partner across the human health value chain.
Strategic Advantages
- Vertically integrated model from strain selection to finished dosage forms
- Strong clinical evidence base and global regulatory support
- Multi-format product offerings suitable for diverse age groups and health needs
- Highly adaptable to market trends, including clean-label, allergen-free, and vegan claims
- Global logistics and documentation readiness for rapid market entry
Major Achievements
- Developed Lafti® L10, one of the most widely studied immune health probiotic strains
- Recognized as a top global probiotic supplier by industry associations
- Named a key contributor to the International Scientific Association for Probiotics and Prebiotics (ISAPP)
- Continuous expansion of intellectual property portfolio, including strain patents and delivery system innovations
Lallemand Health Solutions continues to be a global leader in probiotic innovation, combining microbiology expertise with scientific rigor to provide effective, stable, and market-ready health solutions that meet the evolving needs of consumers and healthcare providers worldwide.
